- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| STRUCTURE THERAPEUTICS Aktie jetzt für 0€ handeln | ||||
| 08.05. | Structure Therapeutics reports Q1 results | 1 | Seeking Alpha | |
| 08.05. | Structure Therapeutics Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | |
| 08.05. | Structure Therapeutics Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 02.05. | Citi sets Structure Therapeutics stock Buy rating, $60 target | 7 | Investing.com | |
| 22.04. | H.C. Wainwright maintains buy on Structure Therapeutics shares | 6 | Investing.com | |
| 15.04. | JMP maintains $87 target on Structure Therapeutics shares | 8 | Investing.com | |
| 14.04. | Structure Therapeutics-Aktien steigen nach Pfizers Ausstieg aus Adipositas-Medikament | 14 | Investing.com Deutsch | |
| 14.04. | Structure Therapeutics shares rise on Pfizer's obesity drug exit | 7 | Investing.com | |
| 14.04. | What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? | 13 | Benzinga.com | |
| 03.03. | Leerink cuts Structure Therapeutics target to $60, keeps outperform | 3 | Investing.com | |
| 28.02. | JMP cuts Structure Therapeutics price target to $87 | 6 | Investing.com | |
| 27.02. | Structure Therapeutics reports Q4 results | 2 | Seeking Alpha | |
| 27.02. | Structure Therapeutics Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | |
| 27.02. | Structure Therapeutics Inc. - 10-K, Annual Report | - | SEC Filings | |
| 27.02. | Structure Therapeutics Inc. - 8-K, Current Report | - | SEC Filings | |
| 14.02. | Why Structure Therapeutics Stock Was Stumbling This Week | 8 | The Motley Fool | |
| 06.01. | Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst | 47 | Benzinga.com | |
| 17.12.24 | Structure Therapeutics unveils new obesity drug candidate | 11 | Investing.com | |
| 17.12.24 | Structure Therapeutics Inc.: Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | 2 | GlobeNewswire (USA) | |
| 17.12.24 | Structure Therapeutics Inc. - 8-K, Current Report | - | SEC Filings |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
Das Unternehmen STRUCTURE THERAPEUTICS INC ADR kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 21,745 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STRUCTURE THERAPEUTICS INC ADR finden Sie auf Wallstreet Online.